Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 7.90 7.50 8.30 7.90 7.90 7.90 169,500 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.0 -1.5 -0.5 - 30

Eden Research Share Discussion Threads

Showing 9451 to 9471 of 9825 messages
Chat Pages: Latest  381  380  379  378  377  376  375  374  373  372  371  370  Older
DateSubjectAuthorDiscuss
25/8/2020
06:22
Awwwh that's brilliant, there was one more spot in Shauns downstairs bathroom to fit another approval... if there are anymore approvals he has no more room on his walls so he might finally be incentivised to actually sell something to pay for an extension ... I knew Sean would eventually have to sell something...
bjlk
25/8/2020
06:19
Australia any better for you?
babbler
25/8/2020
06:12
New authorisation for bio-fungicide in Australia hTTps://www.investegate.co.uk/eden-research-plc--eden-/rns/new-authorisation-for-bio-fungicide-in-australia/202008250700040117X/
supersonico
25/8/2020
06:10
Rns = approval of Eden product= yet another apparently stunning opportunity for sales and profits......that just dont seem to make the slightest difference. What is it to date ? £36.5m of shareholder funds sunk over the years, a one way street. People on here bang in about Cedroz. FFS its licenced for sale exactly where ? Exactly !!!! (Belgium and Mexico).Wise up
quazie12
24/8/2020
16:30
He who dares .. Rodney ;) Good luck.
supersonico
24/8/2020
16:05
Super, I'm mindful of what I posted a few days ago, that's mainly why I felt the need to update. No lack of confidence in the proposition, though the management may be another matter. There's a lot of momentum in my other holding atm, notably lacking in EDEN, so I'm kind of riding the wave while it lasts... I'll be back.
brucie5
24/8/2020
15:55
Brucie, I see your wisely assuming that the Eden / TT dream team will rinse and repeat it's annual 'back to school' investor disappointment event. Makes sense.
supersonico
24/8/2020
15:19
Temporarily out of EDEN. Hold the share price right there. I will be back. ;)
brucie5
24/8/2020
06:44
CAGENOLETA hTTps://www.mcazorla.com/en/388/organic-products/fongicides-en-bio/ hTTps://www.mcazorla.com/fitxes-de-seguretat/pdf/fongicides/fr/Cagenoleta_FDS_FR.pdf hTTps://www.mcazorla.com/en/7/home/
supersonico
23/8/2020
12:27
They are par-all-el at it..aka Consolidator.. News. Bayer accelerating innovation of seed-applied technologies hTTp://news.agropages.com/News/NewsDetail---30331.htm
supersonico
21/8/2020
11:32
Eden Research plc joins the NIAB EMR viticulture consortium! NIAB EMR viticulture and wine team are now working together with EDEN research in the frame of the viticulture consortium developing biocontrol solutions for our members and UK vineyards. Adrian Harris and Paul Tuteirihia are both involved into this project ensuring we deliver on such an important topic for our industry. hTTps://www.linkedin.com/posts/julien-lecourt-b11bb898_research-niabviti-ukvineyards-activity-6699632812145819648-zsuo hTTps://www.emr.ac.uk/ A new viticulture consortium comprising NIAB EMR and the leading UK vineyards, Bolney Wine Estate, Chapel Down, Nyetimber, Gusbourne Estate, Halfpenny Green, Hencote and Kingscote vineyards was launched at Fruit Focus (20/7/16) with the aim of providing much-needed underpinning science to the rapidly growing UK quality wine sector. The East Malling Viticulture Research Consortium, Chaired by Campden BRI’s Geoff Taylor, will help direct the focus of the work undertaken at NIAB EMR and to ensure the application of its science will play a significant role in the sustainability and profitability of the UK wine industry. Drawing on the current multi-million pound research programmes across NIAB and a century of R&D success at East Malling in supporting global fruit production, the consortium is seeking to embed and build on the industry’s existing achievements through focussed research and development activity aimed at improved quality, reducing costs and creation of a globally recognised UK science-based viticulture sector. hTTps://www.gbvg.uk/supplier/east-malling-viticulture-consortium
supersonico
20/8/2020
16:17
To finally sum up, Eden research has delivered nothing and served only to destroy shareholder value for the last 10 years. That's some track record! I don't rate the management. I don't rate the current prospects in their key markets. My above post indicates that the micorplastic ban is much further out than some envisaged and indeed hoped for, giving the existing and entrenched encapsulation technologies plenty of time, and also giving plenty of time for others to be developed/tweaked and authorised etc. Corteva's long-term, exclusive agreement with the Finnish agritech company Pro Farm Technologies (a division of Marrone Bio) to develop a range of biological seed treatment products for European growers, which utilises Pro Farm's natural biopolymers (see my above post regarding biopolymers), combined with proprietary and patent-protected formulations, appears to offer a better and more robust and widely proven option compared to Eden's (my interpretation). For the sake long suffering holders, I actually hope that I am wrong!
wan
20/8/2020
13:40
The draft SEAC opinion regarding microplastics is out for consultation and ends Sept 2020. The draft opinion includes the following - To clarify that (bio)degradable polymers are exempt from the restriction on the basis that they do not contribute to the microplastic concern, even though they could remain in the environment for some time after use/release. So other options for encapsulation exist (Corteva have an agreement with Pro Farm/Marrone Bio, which is interesting) I also note the following transitional periods from initial entry into force date to allow sufficient time for stakeholders to comply with the restriction, EiF is indicated as being "approximately 2022" (could arguably be later) - Entry into force (EiF) + 5 years for fertilising products not regulated in the EU as fertilising products under Regulation (EC) No 2019/1009 that do not meet the requirements for biodegradability contained in that Regulation. g. EiF + 8 years for plant protection products as defined in Regulation (EC) No 1107/2009 and biocides as defined in Regulation (EU) 528/2012. h. EiF + 5 years for other agricultural and horticultural uses including seed treatments. Draft opinion of SEAC - hTTps://echa.europa.eu/documents/10162/28a04d6e-3c6c-3416-44ef-1b40240d8534 I didn't notice that inclusion on Eden's twitter feed!
wan
20/8/2020
11:14
Intended to sell down the rest of my holdings this morning and inadvertently pressed the wrong button. So effectively doubling it instead. Then just short of a round number added some more. The excitement is clearly elsewhere in my folio atm, but looks like my unconscious is sending me a message. A small holding, but mine own. Still. ;)
brucie5
20/8/2020
10:38
Good to see Mrs100K not getting distracted. She does like her Rice. post 7722.
supersonico
19/8/2020
17:43
https://twitter.com/edenresearch From today.
investingisatrickygame
19/8/2020
16:13
Eden folk posting about Potatoes and Chips so time to revisit an old post; supersonico - 23 Jul 2019 - 06:11:51 - 6613 of 8022 Eden Research - EDEN Parked Dots and Wild Guesses. The Guess here is that Eden have on going most likely Cedroz, but possibly Sipcam , related trials with Potatoes potentially related to PepsiCo/ Xinova synergy/colaboration. We have not been told anything about potatoes but Eden collect TweetLikes a plenty of Potato growers and their trade bodies. Lofty Powerscourt will have Potato related relationships and I'm not just talking about Nick Dibdens indulgences. No Smoke and Mirrors here but possibly Smokey Bacon. ......Terpenes/ Terpenoids/ Nematicide / Post Harvest. PepsiCo / FC5 Potato / Xinova / Eden The Role of Terpenes as Protectors of the Potato Crop 1.4 Terpenes Terpenoids constitute the largest and most widespread group of plant secondary metabolites, and they display immense structural diversity. Terpenoids are formed from linear arrangements of isoprene units, and are then rearranged and cyclised in order to form the terpenoid carbon skeleton. Terpenoids are classified according to the number of isoprene units from which they are constructed, and these classes include monoterpenes (C10), sesquiterpenes (C15), diterpenes (C20), triterpenes (C30) and tetraterpenes (C40) to name just a few (Stevens 1992). Terpene synthases, a large class of enzymes, are responsible for the diversity observed in terpene carbon skeleton structures. The diversity in terpene structure is also due to the fact that some terpene synthases produce multiple products (Degenhardt, Köllner et al. 2009). Investigation into terpene synthases has been an active area of plant metabolic engineering research in recent years due to the fact that the vast diversity of terpenes may be exploited for biotechnological purposes (Singh and Sharma 2015). These compounds have an array of interesting properties, which may be exploited for medicinal and agrochemical purposes, as well as for flavouring and in cosmetics. As the field of synthetic biology develops, terpenes may be interesting and useful compounds to investigate and exploit, due to their high level of diversity and the wide array of industries to which they may be applied. Terpenes have been identified in this study as being associated with potato crop losses in a variety of different manners. The compound identified as a ‘hatching factor’ for Potato Cyst Nematodes, which stimulates nematodes to hatch in the presence of the host plant, is a triterpenoid produced by potatoes. Understanding of the ecological role and biosynthesis of this triterpenoid will shed light on the reason for the production of this ‘hatching factor’ by the potato, and may also be critical in identifying solutions to the problem of Potato Cyst Nematode infection. 5 Conclusions This study has investigated two problems facing potato growers: Potato Cyst Nematode as a pathogen of the potato crop, and the problem of sprouting inhibition whilst the potato crop is in storage. Whilst the study has been relatively broad in scope, several key points have been highlighted, which may be key to improving potato crop productivity, both with regards to mitigating against pathogenic factors, and preventing losses in storage. The role of terpenes, both as products of the potato, and as compounds used to protect the potato, have been discussed throughout the study, and the conclusions drawn support the statements made by Singh and Sharma (2015) suggesting that the vast array of terpenes may be exploited for their biotechnological purposes. Furthermore, a deeper understanding of the ecological role of terpenes produced by potato and other plants may result in highly specific applications and uses for such metabolites. hTTps://ueaeprints.uea.ac.uk/58550/1/Alexandra_Holden_-MSc_by_Research_September_2015.pdf hTTps://71republic.com/2019/04/29/patent-laws-pepsico-fc5-potato/ hTTps://www.xinova.com/companies/ hTTps://potatoes.ahdb.org.uk/sites/default/files/publication_upload/R440%20WP2.pdf
supersonico
19/8/2020
14:23
Last 50 posts most interesting - Wan I think has identified the key risk factor with his posts 1062 and 1069 - Historical failure plus transparency failure by management to advise which and why "breakthrough opportunites" have disappeared to la-la land, They may make it with Sustaine but after full and many years DD on this dog i doubt if I will be betting the farm!! Thanks Wan for all your input - If you ever change your mind please det me know by Private Message and a note of your favourite tipple!!!
pugugly
19/8/2020
11:54
You seem to missing the point,if vineyards are devoid of grapes, or the market for them is not commercially viable to support the buying of plant protection products, why would there be much of a market in the second half? Thus, Eden should be able to provide an update on any impact at the half year. With regard to your last point, some companies, where the management have a track record of routinely delivering, it's worth doing the exercise, but I am not going to get drawn into undertaking much effort with Eden, not least on an agreement that did not include any form of upfront payment and an unknown outcome.
wan
19/8/2020
11:24
Wan, I don't personally believe that Mevalone and grapes is Eden's main thrust. That said, this string of Eden's business which is their currently may well be impacted by Covid-19. However, I think Eden would have been more affected by Covid-19 on Mevalone had they had much greater market penetration, so I would expect the impact on Eden to be less so. I agree on management in the way you have described it. Plc's are scrutinised and Eden is no exception. They might be in the shop window, but for the wrong reasons and they need a big win to change this. Hopefully, that will start with Corteva. I wouldn't personally place any consideration on Eden's half-year results because A) Mevalone typically impacts Eden in the second half of the year and B) it is not going to change the Eden narrative. Cedroz sits between these two and it would have been nice to have more regulatory approvals on this by now to have started generating a second revenue line and one that will likely be bigger than Mevalone. Hopefully, Dr Michael Carroll has some influence here to assist. So I'll go back to my original post and the assumptions I asked you to make to come up with a value in the event that Corteva proceeds to a commercial arrangement by January 2021. In those circumstances, what value would you place on Eden?
investingisatrickygame
19/8/2020
11:09
The main thrust should be obvious, grapes are a key market for Eden! It is now clear that many vineyards and wine markets have been heavily impacted, and given the level of uncertainty at the time Eden last reported, it's not exactly difficult to understand there is likely to have been some commercial impact in what is still Eden's key market. Btw, management is another focus, and their routine misses on commentary and guidance! Investors have not got long to find out though, as the Half Year Results were reported mid September last year.
wan
Chat Pages: Latest  381  380  379  378  377  376  375  374  373  372  371  370  Older
ADVFN Advertorial
Your Recent History
LSE
EDEN
Eden Resea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201124 18:15:19